ETF Holdings Breakdown of RPRX

News associated with RPRX

Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 07:44:55

Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)

Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 08:29:08

Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60

Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 05:14:52

Stock Traders Buy High Volume of Royalty Pharma Put Options (NASDAQ:RPRX)

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) saw some unusual options trading on Thursday. Stock traders purchased 4,237 put options on the stock. This is an increase of 344% compared to the typical volume of 954 put options. Institutional Trading of Royalty Pharma Institutional investors and hedge funds have recently modified their holdings of […] - 2025-03-28 07:07:01

Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Corient Private Wealth LLC

Corient Private Wealth LLC lifted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 86.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 46,249 shares of the biopharmaceutical company’s stock after acquiring an additional 21,383 shares during the period. Corient Private Wealth LLC’s holdings in Royalty Pharma were worth $1,180,000 at the […] - 2025-03-27 08:10:50

Royalty Pharma plc (NASDAQ:RPRX) Stake Lowered by HighTower Advisors LLC

HighTower Advisors LLC decreased its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 173,411 shares of the biopharmaceutical company’s stock after selling 9,177 shares during the period. HighTower Advisors […] - 2025-03-20 07:45:04

Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by M&T Bank Corp

M&T Bank Corp boosted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 25.2% during the 4th quarter, HoldingsChannel reports. The fund owned 23,467 shares of the biopharmaceutical company’s stock after buying an additional 4,718 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $599,000 as of its most […] - 2025-03-13 07:47:00

Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Victory Capital Management Inc.

Victory Capital Management Inc. raised its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 15.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 978,211 shares of the biopharmaceutical company’s stock after buying an additional 129,176 shares during the quarter. Victory Capital Management Inc.’s holdings in Royalty Pharma were worth $24,954,000 […] - 2025-03-11 08:58:55

State of Michigan Retirement System Buys 2,700 Shares of Royalty Pharma plc (NASDAQ:RPRX)

State of Michigan Retirement System boosted its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 16.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,400 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-03-10 08:44:52

Allworth Financial LP Raises Position in Royalty Pharma plc (NASDAQ:RPRX)

Allworth Financial LP lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 417.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,087 shares of the biopharmaceutical company’s stock after acquiring an additional 877 shares during the quarter. Allworth Financial LP’s holdings in Royalty Pharma were worth $28,000 as of […] - 2025-02-27 08:28:51

Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week High on Strong Earnings

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $32.72 and last traded at $32.15, with a volume of 1138540 shares traded. The stock had previously closed at $31.72. The biopharmaceutical company […] - 2025-02-12 06:37:01

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. decreased its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 75,068 shares of the biopharmaceutical company’s stock after selling 966 shares during […] - 2025-02-11 09:59:05

Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Rating of “Buy” from Brokerages

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to […] - 2025-02-11 09:04:54

Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Blue Trust Inc.

Blue Trust Inc. boosted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 31.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,579 shares of the biopharmaceutical company’s stock after acquiring an additional 376 shares during the quarter. Blue Trust Inc.’s holdings […] - 2025-02-10 18:12:59

RPRX institutional holdings

Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119 Stack trace: #0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query() #1 {main} thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119

Date	ETF ISIN/Name	Num Shares	Book value